Cystinosis is an autosomal recessive disorder characterized by a high intracellular cystine concentration. To establish an in vitro model of this disorder and examine the mechanism of the proximal tubule transport defect seen with elevated intracellular cystine concentrations, rabbit proximal convoluted tubules (PCT) were perfused in vitro. PCTs were loaded with cystine using cystine dimethyl ester, a permeative methyl ester derivative. Bath cystine dimethyl ester (0.5 mM) reduced volume absorption (JV) (0.67±0.07 to 0.15±0.09 nl/mm min, P < 0.01), bicarbonate transport (JTcO2) (47.2±4.9 to 11.1±2.8 pmol/mm * min, P < 0.001) and glucose transport (JGLU) (34.1±1.5 to 19.7±1.5 pmol/mm -min, P < 0.001). The methyl esters of leucine (0.5 mM), and tryptophan (0.5 and 2.0 mM) had no effect on these parameters. To examine if intracellular reduction of cystine to cysteine could contribute to the inhibition in transport, the effect of bath cysteine methyl ester on proximal tubular transport was examined. Bath cysteine methyl ester (2 but not 0.5 mM) resulted in an inhibition in JV, JGLU, and JTCO2. Cystine dimethyl ester had no effect on mannitol or bicarbonate permeability. These data are consistent with intracellular proximal tubular cystine accumulation resulting in an inhibition of active transport. (J. Clin. Invest. 1990. 85:340-344.) cystinosis * cystine dimethyl ester * Fanconi syndrome
Introduction
Cystinosis is an autosomal recessive disorder characterized by a high intracellular cystine concentration (1) (2) (3) (4) . The cystine accumulation is localized predominantly in lysosomes (5, 6) , where a decrease in carrier-mediated efflux of cystine has been described (7) (8) (9) (10) . This defect eventually leads to the accumulation of cystine in multiple organ systems including the bone marrow, thyroid gland, conjunctival cells, and kidney leading to the Fanconi syndrome (1) . Inevitably, these patients develop end-stage renal disease and require dialysis or renal transplantation (2) .
The inability to achieve an elevated intracellular concentration of the relatively impermeable amino acid cystine has limited initial investigations into the pathogenesis of cystinosis. However, Goldman and Kaplan ( 11) and Reeves (12) dem-onstrated that isolated lysosomes could be loaded with amino acids using the permeable methyl ester derivative. Intralysosomal esterases cleave the methyl ester leaving the less permeable amino acid in a high concentration. Thus, the dimethylester of cystine has been used by several investigators to examine the pathogenesis of cystinosis (7) (8) (9) (10) 13 ).
Steinherz et al. incubated normal leukocytes with cystine dimethyl ester and demonstrated an increase in abnormal granules using electron microscopy (8) . These abnormal granules were lysosomal, whereas nonlysosomal granules remained intact. These authors confirmed that incubation of normal neutrophils with cystine dimethyl ester produced compartmentalization of cystine into lysosomes by demonstrating an almost sevenfold increase in the cystine content ofthe granular fraction compared with the supernatant fraction of these cells (8) . Recently, Foreman et al. showed that renal cortical tubule suspensions incubated with cystine dimethyl ester have an intracellular cystine content comparable to that found in patients with cystinosis whose kidneys were removed at transplantation (14) .
The purpose of the present in vitro microperfusion study was to develop an in vitro model of the Fanconi syndrome of cystinosis. Acute cystine loading, using cystine dimethyl ester in the isolated perfused rabbit proximal convoluted tubule (PCT),' resulted in an inhibition in transepithelial potential difference (PD), volume absorption (Jv), bicarbonate transport (JTCo2), and glucose transport (JGLU). The inhibition in transport with intracellular cystine loading was not due to an increase in paracellular permeability, but rather to an inhibition of active transport.
Methods
Isolated segments of randomly dissected midcortical and juxtamedullary rabbit PCTs were perfused as previously described (15, 16 The transepithelial PD, in millivolts, was measured by using the perfusion pipette as the bridge into the tubular lumen. The perfusion and bath solutions were connected to the recording and reference calomel half-cells, via a bridge containing an ultrafiltrate of the bathing solution in series with a 3.6 M KCI/0.9 M KNO3 agarose bridge. This arrangement avoided direct contact of KCI/KNO3 agarose bridges with the solution that bathed the tubule. In addition, the liquid junction potential at the bridge containing ultrafiltrate and the protein-containing bath solution is equal and opposite to the Donnan potential across the tubule. Thus, under these conditions the measured PD is that due to active ion transport (18) . In experiments where the perfusate and bathing solutions were not the same, the transepithelial PD was corrected for the measured liquid junction potential. The recording and reference calomel half-cells were connected to the high and low impedance side, respectively, of an electrometer (model 602; Keithley Instruments, Inc., Cleveland, OH).
To examine whether cystine dimethyl ester (Sigma Chemical Co., St. Louis, MO) has an effect on proximal tubular transport, tubules were perfused with an ultrafiltrate-like solution and bathed in a serum-like albumin solution during the control period. During the experimental period, 0.5 mM L-cystine dimethyl ester was added to the bathing solution. JV, PD, JTCO2, and JGLU were measured in the control period and 10 min after the addition of 0.5 mM L-cystine dimethyl ester. To determine if the methyl esters of other amino acids affected transport, 0.5 mM L-leucine methyl ester (0.5 mM) and L-tryptophan methyl ester (0.5 and 2.0mM) (Sigma Chemical Co.) were added to the bathing solution in different protocols. To examine the possibility that intracellular cysteine, resulting from the reduction of intracellular cystine, is a potential toxin, 0.5, 1, and 2 mM L-cysteine methyl esters were added to the bathing solution. In each of these protocols, the effect of the amino acid methyl ester on JV, PD, JGLU, and JTCO2 was examined.
To determine if cystine dimethyl ester inhibited transport by increasing proximal tubule permeability, mannitol and bicarbonate permeabilities (Pmann and PHco3) were measured. PCTs were perfused with a solution containing 10 mM mannitol, 1I10 mM NaCl, 5 mM NaHCO3, 5 mM KCI, 1 mM MgSO4, 1 mM Na2HPO4, 30 mM Na gluconate, 1.8 mM CaCI2, and 1 mM acetazolamide. The bathing solution was an ultrafiltrate-like solution containing 6 g/dl of albumin and I mM acetazolamide. ['4C]Mannitol (50 uCi/ml) was added to the perfusate so that Pmann could be calculated. These solutions were designed to give a net J, of zero in the presence of a mannitol and bicarbonate gradient. (20) .
There were at least three measurements of each parameter in a given period for each tubule. The mean values for individual periods in a given tubule were used to calculate the mean value for that period. Data are expressed as a mean±SEM. The t test for paired data was used to determine statistical significance.
Results
The first set of experiments examined the effect of 0.5 mM bath L-cystine dimethyl ester on J., JTCo2, JGLU, and PD. The mean tubular length was 1.9±0.2 mm and the perfusion rates were 11.12±0.27 and 10.94±0.33 nl/min in the control and experimental periods, respectively. Fig. 1 shows the effect of cystine dimethyl ester on Jv and PD. Jv was 0.67±0.07 in the control period and decreased to 0.15±0.09 nl -mm-I min-I after the addition of cystine dimethyl ester (P < 0.001). The transepithelial PD was -3.2±0.4 in the control period and decreased to -0.4±0.2 mV after the addition of cystine dimethyl ester (P < 0.001). The effect of cystine dimethyl ester on JGLU and JTCO is shown on Fig. 2 . JGLU in the control and experimental periods were 34.1±1.5 and 19.7±1.5 pmol mm--min-', respectively (P < 0.001). JTCO2 was 47.2±4.9 in the control period and decreased to 11.1±2.8 pmol -mm-* min-I after the addition of cystine dimethyl ester (P < 0.0001). These data demonstrate that cystine dimethyl ester inhibits JV, PD, JGLU, and JTCO2 in the PCT.
The next experiments were designed to examine if the methyl esters of other amino acids also inhibited transport in the PCT. The effects of L-leucine methyl ester (0.5 mM) and In experiments examining the effect of L-leucine methyl ester (n = 6) on proximal tubular transport, the mean tubular length was 1.5±0.3 mm. The perfusion rates in the control and experimental periods were 11.01±0.25 and 10.54±0.35 nl/ min, respectively. JV in the control period was 0.64±0.10 and 0.5 8±0.09 nl* mm-' -min-' after the addition of leucine methyl ester (P = 0.29). PD was -3.1±0.3 and -3.5±0.5 mV in the control and experimental periods, respectively. As shown in Figs. 4 and 5, leucine methyl ester had no effect on JTCO2 and JGLU. In experiments examining the effect of 0.5 mM L-tryptophan methyl ester (n = 5 in all but JTCO2, where n = 4) on proximal tubular transport, the tubular length was 1.9±0.1 mm. The perfusion rates in the control and experimental periods were 11.34±0.27 and 1 1.04±0.13 nl/min, respectively. J, in the control period was 0.58±0.03 nl mm-' -min-' and 0.58±0.03 nl-mm-' * min-' after the addition of tryptophan methyl ester (P = 0.88). PD was -3.2±0.7 and -3.5±0.8 mV in the control and experimental periods, respectively. Tryptophan methyl ester (0.5 mM) had no effect on JTCO2 or JGLU (Figs. 4 and 5) . To examine if a higher concentration of an amino methyl ester had an effect on proximal tubular transport, 2.0 mM L-tryptophan methyl ester was examined in four tubules. The perfusion rates in the control and experimental periods were 11.01±0.21 and 11.t9±0.42 nl/min, respectively, and the mean tubular length was 1.7±0.2 mm. J. was 0.57±0.08 in the control period and 0.65±0.12 ni -mm-' -min-' after the addition of 2.0 mM tryptophan methyl ester (P = 0.12). PD was -4.1± 1.0 and -4.3± 1.1 mV in the control and experimental period, respectively. 2 mM tryptophan methyl ester had no effect on JGLU and JTCO2 (Figs. 4 and 5) . Thus, neither leucine nor tryptophan methyl ester affected proximal tubular transport, demonstrating that amino acid methyl esters do not have a nonspecific toxic effect on the proximal tubule.
The inhibition in proximal tubular transport resulting from cellular cystine loading could be due to the high concentration of intracellular cystine or potentially to its reduction to cysteine. To examine this possibility, the effect of 0.5, 1.0, and Table II , cystine dimethyl ester did not affect Pmann (n = 5) or PHCO3 (n = 4).
Discussion
This in vitro microperfusion study examined the effect of cystine dimethyl ester on proximal tubular transport in the isolated perfused tubule. Addition of 0.5 mM cystine dimethyl ester to the bathing solution resulted in inhibition of J., JGLU, and JTCO2 in the PCT. Addition ofthe methyl esters ofleucine, tryptophan, and cysteine to the bathing solution in the same concentration had no effect. However, 1 mM bath cysteine methyl ester resulted in the inhibition of J, and JGLU. 2 mM bath cysteine methyl ester resulted in a greater decrease in the transport of these solutes as well as an inhibition in JTCO2. The addition of cystine dimethyl ester to the bathing solution resulted in no change in epithelial membrane permeability consistent with cystine accumulation resulting in a decrease in active transport. These data demonstrate that cystine dimethyl ester inhibits transport in the PCT, and serves as an in vitro model for examination ofthe proximal tubular defects seen in cystinosis.
Cystinosis is the most common cause of the Fanconi syndrome in children. However, a model of this disease has been lacking. Recently, studies have demonstrated that intraperitoneal injections of cystine dimethyl ester in Sprague-Dawley rats can produce a diuresis, and an increase in glucose, phosphate, and a-amino nitrogen excretion (13) . There was no change in creatinine clearance in this model, and there were no histopathological changes in these kidneys demonstrated by either light or electron microscopy (13) . In the same study, unperfused renal cortical tubule suspensions were incubated for 10 min with 2 mM cystine dimethyl ester. This led to a decrease in the uptake of the amino acids L-lysine, L-glycine, and L-taurine and the nonmetabolizable analogue of glucose, a-methyl glucoside. In the current study we examined proximal tubule transport directly. Perfusing the tubule with an ultrafiltrate-like solution and bathing the tubule in a serumlike albumin solution allowed evaluation of solute transport in a paired fashion in individual proximal tubules. This study directly demonstrates that intracellular cystine-loading inhibits proximal tubule transport.
In the cystine dimethyl ester model of the Fanconi syndrome, we examined ifan increase in proximal tubular permeability was a factor to explain the decrease in net transport.
PCTs were perfused with a solution designed to have no net J., and a PD of zero at 380C. A lumen to bath mannitol concentration gradient and bath to lumen bicarbonate gradient in the presence ofacetazolamide allowed measurement ofpermeability of both solutes on a paired basis. Addition of cystine dimethyl ester to the bathing solution had no affect on the permeability of mannitol or bicarbonate. Thus, the decreased absorption in this model is due to the inhibition of active transport.
Incubation of tubule suspensions with cystine dimethyl ester led to levels of intracellular cystine comparable to that measured in kidney tissue of cystinotics who had nephrectomies before transplantation (13, 14) . This level is substantially higher than that found in cultured leukocytes and fibroblasts of patients with cystinosis (2) (3) (4) . In addition to the marked elevation in intracellular cystine, there was about a fivefold increase in cysteine when measured by HPLC (13) . Intraperitoneal injections of cystine dimethyl ester in rats, which led to the development of the Fanconi syndrome, resulted in elevated renal cysteine. Neither cystine nor cystine dimethyl ester was present ( 13) . To directly examine whether an elevation in intracellular cysteine can inhibit proximal tubular transport, the effect of bath cysteine methyl ester was examined. 0.5 mM bath cysteine methyl ester caused a small but significant decrease in PD, but no change in J4, JGLU, or JTCO2, 1 mM cysteine methyl ester resulted in an inhibition in J., PD, and JGLU. 2 mM cysteine methyl ester caused a greater inhibition in the transport of these solutes as well as an inhibition in JTCO2. This inhibition was not the result of a nonspecific effect of amino acid methyl ester since 2 mM tryptophan methyl ester had no effect on proximal tubule transport. Cystinosis is characterized by a high intracellular cystine concentration. However, the nephrotoxic compound in this disorder has not been established. Intracellular cystine is most likely the cellular toxin in cystinosis as well as in this in vitro model. The elevated levels ofcysteine measured in vivo and in vitro after addition of cystine dimethyl ester may be the result of the reduction of intracellular cystine. The role of intracellular cysteine is unclear but may be of importance. In conclusion, intracellular cystine loading of PCTs with cystine dimethyl ester inhibits active transport and serves as an in vitro model for examining the tubular defects in nephropathic cystinosis.
